Our recent crystal structure of TREX1 in complex with a small molecule inhibitor is now available online. #drugdiscovery #cachechallenge https://t.co/M2pwgxxAcc

New Blog Post 📢 Learn how @HalabelianLab utilizes AI-driven hit-finding technologies to discover small molecules targeting the WDR protein family and help elucidate the dark proteome. #OpenScience #drugdiscovery #AI https://t.co/gqVrm7UzEZ

A comprehensive study by @HalabelianLab reveals the interaction of a small molecule which binds to Cbl-b and acts as an intramolecular glue locking the protein in an inactive state. Read more:

Structural and biophysical characterization of a small molecule binding to Cbl-b E3 ligase reveals an intermolecular glue mechanism locking the protein in an inactive state: https://t.co/e8q9SAA9kV @HalabelianLab @thesgconline

WDR proteins are a large, druggable, and underexplored target class with strong disease associations. @HalabelianLab just released several WDR structures in complex with inhibitors, which were identified using DEL-ML, in collaboration with @Relay_Tx, @XChemInc and @Google.

Exciting to share that our DCAF1 manuscript is now available online. It was great collaborating with the OICR team to advance this molecule into a nanomolar affinity DCAF1 ligand.

Our recent structure of CBL-B in complex with N-Aryl isoindolin-1-one inhibitor is now released. https://t.co/t4DPGZueGS #E3ligase